Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Proc Natl Acad Sci U S A ; 113(52): E8482-E8491, 2016 12 27.
Article in English | MEDLINE | ID: mdl-27956638

ABSTRACT

Postsynaptic density protein 95 (PSD95) and synapse-associated protein 97 (SAP97) are homologous scaffold proteins with different N-terminal domains, possessing either a palmitoylation site (PSD95) or an L27 domain (SAP97). Here, we measured PSD95 and SAP97 conformation in vitro and in postsynaptic densities (PSDs) using FRET and EM, and examined how conformation regulated interactions with AMPA-type and NMDA-type glutamate receptors (AMPARs/NMDARs). Palmitoylation of PSD95 changed its conformation from a compact to an extended configuration. PSD95 associated with AMPARs (via transmembrane AMPAR regulatory protein subunits) or NMDARs [via glutamate ionotropic receptor NMDA-type subunit 2B (GluN2B) subunits] only in its palmitoylated and extended conformation. In contrast, in its extended conformation, SAP97 associates with NMDARs, but not with AMPARs. Within PSDs, PSD95 and SAP97 were largely in the extended conformation, but had different orientations. PSD95 oriented perpendicular to the PSD membrane, with its palmitoylated, N-terminal domain at the membrane. SAP97 oriented parallel to the PSD membrane, likely as a dimer through interactions of its N-terminal L27 domain. Changing PSD95 palmitoylation in PSDs altered PSD95 and AMPAR levels but did not affect NMDAR levels. These results indicate that in PSDs, PSD95 palmitoylation, conformation, and its interactions are dynamic when associated with AMPARs and more stable when associated with NMDARs. Altogether, our results are consistent with differential regulation of PSD95 palmitoylation in PSDs resulting from the clustering of palmitoylating and depalmitoylating enzymes into AMPAR nanodomains segregated away from NMDAR nanodomains.


Subject(s)
Disks Large Homolog 4 Protein/metabolism , Lipoylation , Post-Synaptic Density , Receptors, Glutamate/metabolism , Adaptor Proteins, Signal Transducing/metabolism , Animals , Discs Large Homolog 1 Protein , Green Fluorescent Proteins/metabolism , HEK293 Cells , Hippocampus/metabolism , Humans , Membrane Proteins/metabolism , Mutation , Neurons/metabolism , Protein Domains , Protein Multimerization , Rats , Rats, Sprague-Dawley , Receptors, N-Methyl-D-Aspartate/metabolism
2.
Nature ; 456(7224): 904-9, 2008 Dec 18.
Article in English | MEDLINE | ID: mdl-19092927

ABSTRACT

Palmitoylation regulates diverse aspects of neuronal protein trafficking and function. Here a global characterization of rat neural palmitoyl-proteomes identifies most of the known neural palmitoyl proteins-68 in total, plus more than 200 new palmitoyl-protein candidates, with further testing confirming palmitoylation for 21 of these candidates. The new palmitoyl proteins include neurotransmitter receptors, transporters, adhesion molecules, scaffolding proteins, as well as SNAREs and other vesicular trafficking proteins. Of particular interest is the finding of palmitoylation for a brain-specific Cdc42 splice variant. The palmitoylated Cdc42 isoform (Cdc42-palm) differs from the canonical, prenylated form (Cdc42-prenyl), both with regard to localization and function: Cdc42-palm concentrates in dendritic spines and has a special role in inducing these post-synaptic structures. Furthermore, assessing palmitoylation dynamics in drug-induced activity models identifies rapidly induced changes for Cdc42 as well as for other synaptic palmitoyl proteins, suggesting that palmitoylation may participate broadly in the activity-driven changes that shape synapse morphology and function.


Subject(s)
Lipoylation , Neurons/metabolism , Proteomics , Synapses/metabolism , Alternative Splicing/genetics , Animals , Cells, Cultured , Cerebral Cortex/cytology , Cerebral Cortex/embryology , Dendrites/metabolism , Models, Neurological , Organ Specificity , Proteome/metabolism , Rats , cdc42 GTP-Binding Protein/genetics , cdc42 GTP-Binding Protein/metabolism
3.
J Biol Chem ; 283(10): 6022-32, 2008 Mar 07.
Article in English | MEDLINE | ID: mdl-18174175

ABSTRACT

Recent evidence suggests that in addition to alpha4beta2 and alpha3-containing nicotinic receptors, alpha6-containing receptors are present in midbrain dopaminergic neurons and involved in the nicotine reward pathway. Using heterologous expression, we found that alpha6beta2, like alpha3beta2 and alpha4beta2 receptors, formed high affinity epibatidine binding complexes that are pentameric, trafficked to the cell surface, and produced acetylcholine-evoked currents. Chronic nicotine exposure up-regulated alpha6beta2 receptors with differences in up-regulation time course and concentration dependence compared with alpha4beta2 receptors, the predominant high affinity nicotine binding site in brain. The alpha6beta2 receptor up-regulation required higher nicotine concentrations than for alpha4beta2 but lower than for alpha3beta2 receptors. The alpha6beta2 up-regulation occurred 10-fold faster than for alpha4beta2 and slightly faster than for alpha3beta2. Our data suggest that nicotinic receptor up-regulation is subtype-specific such that alpha6-containing receptors up-regulate in response to transient, high nicotine exposures, whereas sustained, low nicotine exposures up-regulate alpha4beta2 receptors.


Subject(s)
Ganglionic Stimulants/pharmacology , Mesencephalon/metabolism , Nerve Tissue Proteins/biosynthesis , Nicotine/pharmacology , Receptors, Nicotinic/biosynthesis , Up-Regulation/drug effects , Animals , Cell Line , Mesencephalon/cytology , Neurons/cytology , Neurons/metabolism , Protein Transport/drug effects , Rats , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...